Sopra Steria Group SA
Sopra Steria Group SA (SPSAF) Financial Performance & Income Statement Overview
Review Sopra Steria Group SA (SPSAF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Sopra Steria Group SA (SPSAF) Income Statement & Financial Overview
Explore comprehensive income reports for Sopra Steria Group SA SPSAF, broken down by year and quarter.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $2.83B | $2.95B | $2.97B | $2.84B |
Cost of Revenue | $2.55B | $2.58B | $2.71B | $2.60B |
Gross Profit | $275.20M | $373.60M | $256.10M | $240.60M |
Gross Profit Ratio | $0.10 | $0.13 | $0.09 | $0.08 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $13.20M | $111.90M | $22.90M |
Operating Expenses | $11.40M | $143.90M | -$3.20M | $32.80M |
Total Costs & Expenses | -$2.56B | $2.72B | $2.71B | $2.63B |
Interest Income | $5.10M | $0.00 | $3.60M | $2.90M |
Interest Expense | $33.90M | $8.80M | $27.50M | $15.60M |
Depreciation & Amortization | $124.20M | $126.20M | $136.50M | $80.10M |
EBITDA | $368.20M | $375.60M | $293.10M | $260.40M |
EBITDA Ratio | $0.13 | $0.13 | $0.13 | $0.10 |
Operating Income | $263.80M | $229.70M | $259.30M | $207.80M |
Operating Income Ratio | $0.09 | $0.08 | $0.09 | $0.07 |
Other Income/Expenses (Net) | -$53.70M | -$19.50M | -$129.80M | -$23.80M |
Income Before Tax | $210.10M | $210.20M | $129.50M | $164.70M |
Income Before Tax Ratio | $0.07 | $0.07 | $0.04 | $0.06 |
Income Tax Expense | $63.50M | $33.30M | $69.20M | $42.50M |
Net Income | $127.70M | $123.20M | $71.20M | $112.50M |
Net Income Ratio | $0.05 | $0.04 | $0.02 | $0.04 |
EPS | $6.52 | $6.11 | $3.52 | $5.57 |
Diluted EPS | $6.33 | $6.01 | $3.42 | $5.52 |
Weighted Avg Shares Outstanding | $19.61M | $20.16M | $20.25M | $20.20M |
Weighted Avg Shares Outstanding (Diluted) | $20.18M | $20.49M | $20.79M | $20.40M |
Over the last four quarters, Sopra Steria Group SA achieved steady financial progress, growing revenue from $2.84B in Q2 2023 to $2.83B in Q4 2024. Gross profit stayed firm with margins at 10% in Q4 2024 versus 8% in Q2 2023. Operating income totaled $263.80M in Q4 2024, maintaining a 9% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $368.20M. Net income rose to $127.70M, with EPS at $6.52. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan